About WuXi Biology
Part of the WuXi Discovery Services Platform
WuXi Discovery Services supports clients in the discovery and development of future therapeutics. Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, we work collaboratively to rapidly advance programs from target through to preclinical selection and beyond. This integration of capabilities allows a collaborative environment, enabling enhanced efficiency and productivity. We strive to continually develop and enhance our scientific capabilities and technology to maintain its industry leading position. We aim to provide outstanding services to our existing partners and to the broader discovery community.
- A discovery biology enabling platform with more than 2,000 experienced scientists
- Expertise in all major disease areas and target classes, enabling discovery for all modalities
- World class antiviral platform, with an unequalled service capability and capacity in HBV, COVID-19, and other viral diseases
- A High-Throughput Screening (HTS) Center
- A global leader in DNA Encoded Library (DEL) screening, with innovative business models
- CAP-certified pathology and FACS capabilities supporting clinical biomarker services
- The world’s leading integrated, on-line, tumor model database
Our expertise include:
Total Global Employees
Area of Laboratory (sq.m.)
Global Site and Office
WuXi AppTec Discovery Services
Delivering our partners preclinical discoveries through world class capabilities, directed by teams with a reputation for collaboration and scientific excellence.